İRFAN ÇİÇİN

Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician–patient survey

Cicin I.

Scientific Reports, 2026

Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study

Yildiz N.D.

Clinics and Practice, 2026

Continued Cemiplimab Beyond Progression With Addition of Chemotherapy in Patients With Advanced NSCLC With PD-L1 Expression of 50% or Higher: 5-Year Follow-Up From EMPOWER-Lung 1

Garassino M.C.

Jto Clinical and Research Reports, 2026

De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study

Sella T.

Breast, 2026

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein Overexpressing, Nonsquamous, EGFR Wild-type Advanced NSCLC: Updated Analysis of the LUMINOSITY Trial

Girard N.

Jto Clinical and Research Reports, 2026

Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study

Moura A.F.

Current Oncology, 2026

Telemedicine adoption, pandemic-related fear, and treatment adherence in cancer care during COVID-19: a prospective cohort study

Ulkucu A.

Supportive Care in Cancer, 2026

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study

Loriot Y.

Journal of Clinical Oncology, 2026

Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors

Gürbüz, M

JCO GLOBAL ONCOLOGY, 2026

Article

Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors

Gürbüz M.

JCO Global Oncology, 2026

Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy

Shai A.

Breast, 2026

Overall survival with abemaciclib in early breast cancer☆

Johnston S.

Annals of Oncology, 2026